Anheuser-Busch InBev SA/NV (BUD)
USD 50.11
(-3.21%)
USD 50.11
(-3.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 59.38 Billion | 57.78 Billion | 54.3 Billion | 46.88 Billion | 52.32 Billion | 54.61 Billion |
| Cost of Revenue | 29.58 Billion | 26.3 Billion | 23.09 Billion | 19.63 Billion | 20.36 Billion | 20.35 Billion |
| Gross Profit | 29.79 Billion | 31.48 Billion | 31.2 Billion | 27.24 Billion | 31.96 Billion | 34.26 Billion |
| Operating Expenses | 18.01 Billion | 17.21 Billion | 17.22 Billion | 14.52 Billion | 16.2 Billion | 17.1 Billion |
| Selling, General and Administrative Expenses | 18.17 Billion | 17.55 Billion | 17.57 Billion | 15.36 Billion | 16.42 Billion | 17.11 Billion |
| Research and Development Expenses | 256 Million | 268 Million | 298 Million | 296 Million | 291 Million | 276 Million |
| Other Expenses | -501 Million | -338 Million | -346 Million | -845 Million | -221 Million | 249 Million |
| Cost and Expenses | 45.41 Billion | 43.52 Billion | 40.32 Billion | 34.15 Billion | 36.56 Billion | 37.46 Billion |
| Operating Income | 13.96 Billion | 14.51 Billion | 13.82 Billion | 7.8 Billion | 16.09 Billion | 17.1 Billion |
| Interest Expense | 4.59 Billion | 4.44 Billion | 5.23 Billion | 4.99 Billion | 4.89 Billion | 4.61 Billion |
| Income Tax Expense | 2.23 Billion | 1.92 Billion | 2.35 Billion | 1.93 Billion | 2.78 Billion | 2.83 Billion |
| Earnings before Tax | 9.12 Billion | 9.52 Billion | 8.46 Billion | 2.08 Billion | 12.77 Billion | 8.53 Billion |
| Net Income | 5.34 Billion | 5.96 Billion | 4.67 Billion | 148 Million | 9.17 Billion | 4.36 Billion |
| Earnings Per Share Basic | 2.65 | 2.97 | 2.33 | 0.07 | 4.62 | 2.21 |
| Earnings Per Share Diluted | 2.60 | 2.91 | 2.28 | 0.07 | 4.53 | 2.17 |
| Weighted Average Shares Outstanding | 2.01 Billion | 2.01 Billion | 2 Billion | 1.99 Billion | 1.98 Billion | 1.97 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.05 Billion | 2.05 Billion | 2.04 Billion | 1.99 Billion | 2.02 Billion | 2.01 Billion |
| Gross Margin | 0.50 | 0.54 | 0.57 | 0.58 | 0.61 | 0.63 |
| EBIT Margin | 0.32 | 0.33 | 0.36 | 0.27 | 0.42 | 0.37 |
| Profit Margin | 0.09 | 0.10 | 0.09 | 0.00 | 0.18 | 0.08 |
| EBITDA | 18.97 Billion | 18.9 Billion | 17.38 Billion | 11.22 Billion | 22.3 Billion | 17.08 Billion |
| Earnings Before Tax Margin | 0.24 | 0.25 | 0.25 | 0.17 | 0.31 | 0.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 29.88 Billion | 14.54 Billion | 30.03 Billion | 59.38 Billion | 15.57 Billion | 15.12 Billion |
| Cost of Revenue | 13.41 Billion | 6.65 Billion | 13.85 Billion | 29.58 Billion | 7.18 Billion | 7.02 Billion |
| Gross Profit | 16.46 Billion | 7.89 Billion | 16.17 Billion | 29.79 Billion | 8.39 Billion | 8.1 Billion |
| Operating Expenses | 9.24 Billion | 4.25 Billion | 9.11 Billion | 15.94 Billion | 4.36 Billion | -4.59 Billion |
| Selling, General and Administrative Expenses | 9.24 Billion | 4.43 Billion | 9.11 Billion | - | 4.58 Billion | 4.7 Billion |
| Research and Development Expenses | - | - | 256 Million | - | - | - |
| Other Expenses | -90 Million | - | -12 Million | 74 Million | - | -9.29 Billion |
| Cost and Expenses | 22.66 Billion | 10.9 Billion | 22.97 Billion | 45.53 Billion | 11.54 Billion | 2.42 Billion |
| Operating Income | 7.21 Billion | 3.64 Billion | 7.06 Billion | 13.84 Billion | 4.02 Billion | 3.5 Billion |
| Interest Expense | 960 Million | 927 Million | 2.5 Billion | 4.75 Billion | 1 Billion | 1.27 Billion |
| Income Tax Expense | 1.54 Billion | 794 Million | 1.04 Billion | 2.23 Billion | 666 Million | 595 Million |
| Earnings before Tax | 4.64 Billion | 2.27 Billion | 5.08 Billion | 8.82 Billion | 2.63 Billion | 1.2 Billion |
| Net Income | 2.56 Billion | 1.09 Billion | 3.36 Billion | 5.34 Billion | 1.47 Billion | 339 Million |
| Earnings Per Share Basic | 1.28 | 0.54 | 1.69 | - | 0.73 | 0.98 |
| Earnings Per Share Diluted | 1.25 | 0.54 | 1.64 | - | 0.73 | 0.96 |
| Weighted Average Shares Outstanding | 2 Billion | 2 Billion | 1.98 Billion | 2.01 Billion | 2.01 Billion | 2.01 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.04 Billion | 2 Billion | 2.05 Billion | 2.05 Billion | 2.01 Billion | 2.05 Billion |
| Gross Margin | 0.55 | 0.54 | 0.54 | 0.50 | 0.54 | 0.54 |
| EBIT Margin | 0.33 | 0.24 | 0.33 | - | 0.25 | 0.16 |
| Profit Margin | 0.09 | 0.07 | 0.11 | 0.09 | 0.09 | 0.02 |
| EBITDA | 9.8 Billion | 3.54 Billion | 9.96 Billion | - | 3.9 Billion | 2.47 Billion |
| Earnings Before Tax Margin | 0.24 | 0.25 | 0.24 | 0.23 | 0.26 | 0.23 |
AARTIDRUGS
IRRA
300214
PH
NKT
WIX